Explore some of our Top Advisor Awards, Rankings & Media Recognition below
02/05/2026
Aspiriant’s Exclusive Family Office received the Best Multi-family Office up to $25bn award from Private Asset Management. The rating is based on risk-adjusted performance, achievement of client objectives, quality of services for HNW and UHNW clients, and demonstrated excellence in client service during the evaluation period.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results.
02/04/2026
12 Aspiriant Wealth Managers named to Forbes Top Women Wealth Advisors Best-In-State list. The rating is based on qualitative and quantitative factors including experience, assets under management, revenue, compliance record, client retention, and insights from interviews and surveys.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results. Aspiriant does pay an annual fee to maintain a company profile page.
Knowledge is a wonderful thing, especially in the sometimes esoteric world of wealth management. Good news is the same folks who work for you are featured regularly in the world’s most authoritative financial media.
From top wealth manager rankings among America’s best RIA firms to individual honors for our advisors and business leaders, we’re proud to be recognized by our industry peers and experts alike
10/01/2025
Aspiriant named to Forbes Top RIA Firms list. The rating is based on qualitative and quantitative factors including assets under management, revenue trends, compliance history, industry experience, and demonstrated best practices in client service and firm culture.
Aspiriant did not provide compensation in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results. Aspiriant does pay an annual fee to maintain a company profile page.
Disclosure: No fees were paid to obtain any of the awards and rankings. Aspiriant supplied the information upon which the award was based. For award disclosures, please view the link.
09/15/2025
Aspiriant named to Barron’s Top RIA Firms list. The rating is based on assets under management, revenue, compliance history, client retention, team quality, and overall practice, with investment performance not a criterion.
Aspiriant did not provide compensation in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results. Aspiriant does pay an annual fee to maintain a company profile page.
09/04/2025
Rob Francais is a finalist at the Wealth Management Industry Awards. The rating is based on independent expert evaluation of business initiatives for innovation, impact, and scope, with winners determined by weighted rankings. Judges act independently and recuse themselves for conflicts.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results.
08/06/2025
Michelle Eversman named to Forbes Top Next Gen Advisors list. The rating is based on AUM, revenue trends, compliance, experience, and best practices, with portfolio performance not a criterion.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results. Aspiriant does pay an annual fee to maintain a company profile page.
07/11/2025
Aspiriant named to America’s Top RIAS for 2025 list from Financial Advisor. The rating is based on year-end AUM reported by independent RIA firms, with rankings from largest to smallest. Participation is voluntary, and only independently registered advisors serving individual clients are eligible.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results.
05/14/2025
Aspiriant named to UCLA Bruin Business 100 list. The rating recognizes UCLA alumni entrepreneurs for innovation, impact, and leadership, based on overall business achievements and contributions to the Bruin community.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results.
05/08/2025
Aspiriant received the Multi-Family Office ($5 billion to $15 billion AuM/AuA) award from Family Wealth Report. The rating is based on expert review of submissions for excellence, innovation, and impact in wealth management, with winners selected solely on merit.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results.
To stay up-to-date on our latest news and press, follow us on LinkedIn and check out the full list of Aspiriant advisors‘ awards and media appearances below. Have a look.
04/08/2025
Aspiriant named to Forbes Best-In-State Wealth Advisor list. The rating is based on AUM, revenue, compliance, experience, service model, and client impact, with portfolio performance not a criterion.
No compensation was provided in connection with obtaining or using this rating. The rating is not indicative of future performance and does not guarantee investment results. Aspiriant does pay an annual fee to maintain a company profile page.